Achilles Therapeutics Statistics
Total Valuation
MCRP has a market cap or net worth of $74.53 million. The enterprise value is $80.67 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
MCRP has 33.88 million shares outstanding. The number of shares has increased by 17.25% in one year.
Current Share Class | 33.88M |
Shares Outstanding | 33.88M |
Shares Change (YoY) | +17.25% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 71.08% |
Owned by Institutions (%) | 0.16% |
Float | 6.80M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2,104.93 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2,278.52 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.17
Current Ratio | 0.17 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -17.50 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -142.79% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 136.27% |
Revenue Per Employee | $513 |
Profits Per Employee | -$87,968 |
Employee Count | 69 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 2.63 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 48.64 |
Average Volume (20 Days) | 137,832 |
Short Selling Information
The latest short interest is 8,274, so 0.02% of the outstanding shares have been sold short.
Short Interest | 8,274 |
Short Previous Month | 14,590 |
Short % of Shares Out | 0.02% |
Short % of Float | 0.12% |
Short Ratio (days to cover) | 0.12 |
Income Statement
In the last 12 months, MCRP had revenue of $35,405 and -$6.07 million in losses. Loss per share was -$0.20.
Revenue | 35,405 |
Gross Profit | -324 |
Operating Income | -5.75M |
Pretax Income | -5.15M |
Net Income | -6.07M |
EBITDA | -5.46M |
EBIT | -5.75M |
Loss Per Share | -$0.20 |
Full Income Statement Balance Sheet
The company has $13,024 in cash and $6.16 million in debt, giving a net cash position of -$6.15 million or -$0.18 per share.
Cash & Cash Equivalents | 13,024 |
Total Debt | 6.16M |
Net Cash | -6.15M |
Net Cash Per Share | -$0.18 |
Equity (Book Value) | -8.37M |
Book Value Per Share | -0.28 |
Working Capital | -5.71M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$3.66 million and capital expenditures -$465,260, giving a free cash flow of -$4.12 million.
Operating Cash Flow | -3.66M |
Capital Expenditures | -465,260 |
Free Cash Flow | -4.12M |
FCF Per Share | -$0.12 |
Full Cash Flow Statement Margins
Gross Margin | -0.92% |
Operating Margin | -16,232.03% |
Pretax Margin | -17,143.94% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MCRP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -17.25% |
Shareholder Yield | -17.25% |
Earnings Yield | -8.14% |
FCF Yield | -5.53% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MCRP has an Altman Z-Score of -16.68 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -16.68 |
Piotroski F-Score | 1 |